CD34 and colorectal cancer: Celecoxib suppressed tumor growth and angiogenesis, which mediated a decrease in the amount of CD34+ cells, inhibition of COX-2, PGE2 synthesis, and VEGF and MMP-2 mRNA expression in a mouse model of colorectal cancer [270].